SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-19-000031
Filing Date
2019-08-08
Accepted
2019-08-08 16:19:21
Documents
78
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q moderna10-q6302019.htm 10-Q 1537208
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 111723
3 EXHIBIT 31.1 exhibit3116302019.htm EX-31.1 11338
4 EXHIBIT 31.2 exhibit31206302019.htm EX-31.2 10405
5 EXHIBIT 32.1 exhibit3216302019.htm EX-32.1 14592
12 a190425cellmapa03.jpg GRAPHIC 232297
13 a190805pipeline.jpg GRAPHIC 325390
14 modernalogo.jpg GRAPHIC 63925
  Complete submission text file 0001682852-19-000031.txt   9477333

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mrna-20190630.xml EX-101.INS 1900514
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20190630.xsd EX-101.SCH 63472
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20190630_cal.xml EX-101.CAL 79717
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20190630_def.xml EX-101.DEF 322513
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20190630_lab.xml EX-101.LAB 775601
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20190630_pre.xml EX-101.PRE 490621
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 191009800
SIC: 2836 Biological Products, (No Diagnostic Substances)